InflaRx

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.

About IFRX

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is vilobelimab. 

CEO
Niels Christoph Riedemann
CEONiels Christoph Riedemann
Employees
59
Employees59
Headquarters
Jena, Thueringen
HeadquartersJena, Thueringen
Founded
2007
Founded2007
Employees
59
Employees59

IFRX Key Statistics

Market cap
103.88M
Market cap103.88M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
57.58K
Average volume57.58K
High today
$2.67
High today$2.67
Low today
$2.28
Low today$2.28
Open price
$2.50
Open price$2.50
Volume
97.17K
Volume97.17K
52 Week high
$4.99
52 Week high$4.99
52 Week low
$0.7762
52 Week low$0.7762

IFRX Earnings

-$0.40
-$0.26
-$0.13
$0.01
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 23, Pre-Market
ActualExpected Mar 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.